Skip to main content
Premium Trial:

Request an Annual Quote

Igentify: Danielle Gutter, Amanda Swiatocha, Sharon Topolski-Nahmias

Igentify, a digital health company that makes a platform to securely streamline genetic testing, has named Danielle Gutter as VP of global sales; Amanda Swiatocha as VP of marketing; and Sharon Topolski-Nahmias as chief operating officer.

Gutter has more than 20 years of experience in diagnostic sales, including more than 15 years of executive leadership and management experience, Igentify said. She previously contributed to the launch of the oncology divisions at Natera and Counsyl. She holds a BS degree from Widener University.

Swiatocha joins Igentify after 12 years at the Institute for Healthcare Improvement. Before that, she worked in healthcare investment banking at Leerink Swann (now SVB Securities) and in sales at EF Education. She holds an MBA from Boston College and a BA from Williams Colllege.

Topolski-Nahmias joins the company after 17 years at Philips Healthcare in various roles, including general manager of Philips Radiology Informatics and head of the project management office. She holds a BS from Technion and MBA from Haifa University.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.